Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Other Non-Current Liabilities (2018 - 2025)

TELA Bio (TELA) has 8 years of Other Non-Current Liabilities data on record, last reported at $1.6 million in Q3 2025.

  • For Q3 2025, Other Non-Current Liabilities rose 6.78% year-over-year to $1.6 million; the TTM value through Sep 2025 reached $1.6 million, up 6.78%, while the annual FY2024 figure was $1.4 million, 17.51% down from the prior year.
  • Other Non-Current Liabilities reached $1.6 million in Q3 2025 per TELA's latest filing, up from $1.2 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $1.7 million in Q4 2023 and bottomed at $8000.0 in Q1 2021.
  • Average Other Non-Current Liabilities over 5 years is $1.1 million, with a median of $1.3 million recorded in 2022.
  • Peak YoY movement for Other Non-Current Liabilities: soared 16925.0% in 2022, then fell 18.78% in 2025.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $380000.0 in 2021, then surged by 223.95% to $1.2 million in 2022, then skyrocketed by 36.88% to $1.7 million in 2023, then decreased by 17.51% to $1.4 million in 2024, then grew by 12.16% to $1.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Liabilities were $1.6 million in Q3 2025, $1.2 million in Q2 2025, and $1.3 million in Q1 2025.